Literature DB >> 19596861

Distinct structures of scrapie prion protein (PrPSc)-seeded versus spontaneous recombinant prion protein fibrils revealed by hydrogen/deuterium exchange.

Vytautas Smirnovas1, Jae-Il Kim, Xiaojun Lu, Ryuichiro Atarashi, Byron Caughey, Witold K Surewicz.   

Abstract

The detailed structures of prion disease-associated, partially protease-resistant forms of prion protein (e.g. PrP(Sc)) are largely unknown. PrP(Sc) appears to propagate itself by autocatalyzing the conformational conversion and oligomerization of normal prion protein (PrP(C)). One manifestation of PrP(Sc) templating activity is its ability, in protein misfolding cyclic amplification reactions, to seed the conversion of recombinant prion protein (rPrP) into aggregates that more closely resemble PrP(Sc) than spontaneously nucleated rPrP amyloids in terms of proteolytic fragmentation and infrared spectra. The absence of posttranslational modifications makes these rPrP aggregates more amenable to detailed structural analyses than bona fide PrP(Sc). Here, we compare the structures of PrP(Sc)-seeded and spontaneously nucleated aggregates of hamster rPrP by using H/D exchange coupled with mass spectrometry. In spontaneously formed fibrils, very slow H/D exchange in region approximately 163-223 represents a systematically H-bonded cross-beta amyloid core structure. PrP(Sc)-seeded aggregates have a subpopulation of molecules in which this core region extends N-terminally as far as to residue approximately 145, and there is a significant degree of order within residues approximately 117-133. The formation of tightly H-bonded structures by these more N-terminal residues may account partially for the generation of longer protease-resistant regions in the PrP(Sc)-seeded rPrP aggregates; however, part of the added protease resistance is dependent on the presence of SDS during proteolysis, emphasizing the multifactorial influences on proteolytic fragmentation patterns. These results demonstrate that PrP(Sc) has a distinct templating activity that induces ordered, systematically H-bonded structure in regions that are dynamic and poorly defined in spontaneously formed aggregates of rPrP.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19596861      PMCID: PMC2782017          DOI: 10.1074/jbc.M109.036558

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  48 in total

1.  Pathway complexity of prion protein assembly into amyloid.

Authors:  Ilia V Baskakov; Giuseppe Legname; Michael A Baldwin; Stanley B Prusiner; Fred E Cohen
Journal:  J Biol Chem       Date:  2002-03-23       Impact factor: 5.157

2.  Autocatalytic conversion of recombinant prion proteins displays a species barrier.

Authors:  Ilia V Baskakov
Journal:  J Biol Chem       Date:  2003-12-10       Impact factor: 5.157

Review 3.  Emerging principles of conformation-based prion inheritance.

Authors:  Peter Chien; Jonathan S Weissman; Angela H DePace
Journal:  Annu Rev Biochem       Date:  2004       Impact factor: 23.643

4.  Evidence for assembly of prions with left-handed beta-helices into trimers.

Authors:  Cédric Govaerts; Holger Wille; Stanley B Prusiner; Fred E Cohen
Journal:  Proc Natl Acad Sci U S A       Date:  2004-05-21       Impact factor: 11.205

Review 5.  Prions: proteins as genes and infectious entities.

Authors:  Reed B Wickner; Herman K Edskes; B Tibor Roberts; Ulrich Baxa; Michael M Pierce; Eric D Ross; Andreas Brachmann
Journal:  Genes Dev       Date:  2004-03-01       Impact factor: 11.361

6.  From conversion to aggregation: protofibril formation of the prion protein.

Authors:  Mari L DeMarco; Valerie Daggett
Journal:  Proc Natl Acad Sci U S A       Date:  2004-02-24       Impact factor: 11.205

7.  Mouse polyclonal and monoclonal antibody to scrapie-associated fibril proteins.

Authors:  R J Kascsak; R Rubenstein; P A Merz; M Tonna-DeMasi; R Fersko; R I Carp; H M Wisniewski; H Diringer
Journal:  J Virol       Date:  1987-12       Impact factor: 5.103

8.  Synthetic mammalian prions.

Authors:  Giuseppe Legname; Ilia V Baskakov; Hoang-Oanh B Nguyen; Detlev Riesner; Fred E Cohen; Stephen J DeArmond; Stanley B Prusiner
Journal:  Science       Date:  2004-07-30       Impact factor: 47.728

Review 9.  Mammalian prion biology: one century of evolving concepts.

Authors:  Adriano Aguzzi; Magdalini Polymenidou
Journal:  Cell       Date:  2004-01-23       Impact factor: 41.582

10.  Novel proteinaceous infectious particles cause scrapie.

Authors:  S B Prusiner
Journal:  Science       Date:  1982-04-09       Impact factor: 47.728

View more
  46 in total

1.  Solution structure, conformational dynamics, and CD4-induced activation in full-length, glycosylated, monomeric HIV gp120.

Authors:  Miklos Guttman; Maria Kahn; Natalie K Garcia; Shiu-Lok Hu; Kelly K Lee
Journal:  J Virol       Date:  2012-06-06       Impact factor: 5.103

2.  Probing the conformation of a prion protein fibril with hydrogen exchange.

Authors:  Steven M Damo; Aaron H Phillips; Anisa L Young; Sheng Li; Virgil L Woods; David E Wemmer
Journal:  J Biol Chem       Date:  2010-08-02       Impact factor: 5.157

3.  Influence of pH on the human prion protein: insights into the early steps of misfolding.

Authors:  Marc W van der Kamp; Valerie Daggett
Journal:  Biophys J       Date:  2010-10-06       Impact factor: 4.033

Review 4.  Techniques to elucidate the conformation of prions.

Authors:  Martin L Daus
Journal:  World J Biol Chem       Date:  2015-08-26

Review 5.  Prions and the potential transmissibility of protein misfolding diseases.

Authors:  Allison Kraus; Bradley R Groveman; Byron Caughey
Journal:  Annu Rev Microbiol       Date:  2013-06-28       Impact factor: 15.500

6.  Cofactor molecules induce structural transformation during infectious prion formation.

Authors:  Michael B Miller; Daphne W Wang; Fei Wang; Geoffrey P Noble; Jiyan Ma; Virgil L Woods; Sheng Li; Surachai Supattapone
Journal:  Structure       Date:  2013-10-10       Impact factor: 5.006

7.  Prion Protein Prolines 102 and 105 and the Surrounding Lysine Cluster Impede Amyloid Formation.

Authors:  Allison Kraus; Kelsie J Anson; Lynne D Raymond; Craig Martens; Bradley R Groveman; David W Dorward; Byron Caughey
Journal:  J Biol Chem       Date:  2015-07-14       Impact factor: 5.157

8.  Is type 2 diabetes an amyloidosis and does it really matter (to patients)?

Authors:  G J S Cooper; J F Aitken; S Zhang
Journal:  Diabetologia       Date:  2010-03-13       Impact factor: 10.122

9.  Conserved amyloid core structure of stop mutants of the human prion protein.

Authors:  Markus Zweckstetter
Journal:  Prion       Date:  2013-02-13       Impact factor: 3.931

10.  Structural attributes of mammalian prion infectivity: Insights from studies with synthetic prions.

Authors:  Qiuye Li; Fei Wang; Xiangzhu Xiao; Chae Kim; Jen Bohon; Janna Kiselar; Jiri G Safar; Jiyan Ma; Witold K Surewicz
Journal:  J Biol Chem       Date:  2018-10-01       Impact factor: 5.157

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.